Prognostic significance of aneuploidy in non-small cell lung cancer (NSCLC) patients (pts).

被引：0
|
作者：
Dziadziuszko, R [1 ]
Wegrzynowicz, E [1 ]
Kardas, I [1 ]
Limon, J [1 ]
Jassem, J [1 ]
机构：
[1] Med Univ Gdansk, Gdansk, Poland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7319
引用
收藏
页码：695S / 695S
页数：1
相关论文
共 50 条
  • [1] Prognostic significance and origin of plasma KRAS mutations in patients with non-small cell lung cancer (NSCLC)
    Gautschi, Oliver
    Ziegler, Annemarie
    Huegli, Barbara
    Gugger, Mathias
    Ratschiller, Daniel
    Mack, Philip C.
    Kung, Hsing-Jien
    Stahel, Rolf A.
    Gandara, David R.
    Betticher, Daniel C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S443 - S443
  • [2] Aneuploidy carries poor prognosis in non-small-cell lung cancer (NSCLC) patients (pts)
    Wegrzynowicz, E
    Dziadziuszko, R
    Kardas, I
    Limon, J
    Kurowski, K
    Jassem, J
    [J]. LUNG CANCER, 2004, 45 : S34 - S34
  • [3] The CANOPY program: Canakinumab in patients (pts) with non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis G.
    Garon, Edward B.
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Cho, Byoung Chul
    Castro, Gilberto
    De Marchi, Pedro
    Felip, Enriqueta
    Goto, Yasushi
    Greystoke, Alastair
    Lu, Shun
    Lim, Darren Wan Teck
    Papadimitrakopoulou, Vassiliki
    Reck, Martin
    Solomon, Benjamin J.
    Spigel, David R.
    Tan, Daniel Shao-Weng
    Thomas, Michael
    Yang, James Chih-Hsin
    Johnson, Bruce E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [5] Estimation and prognostic significance of six serum tumor markers in non-small cell lung cancer (NSCLC) patients
    Vaslamatzis, M. M.
    Stathopoulos, Ch.
    Kyriou, L.
    Vrionis, E.
    Petraki, C.
    Alevizopoulos, N.
    Patila, E.
    Zoumblios, Ch.
    Nikolaides, H.
    Kourelis, Th.
    Moustafellou, A.
    Delaki, K.
    Xynogalos, S.
    Alexopoulos, C. G.
    [J]. LUNG CANCER, 2006, 52 : S43 - S43
  • [6] Trends in demographics and survival for patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Kubota, K.
    Masuhara, H.
    Hosoya, K.
    Yoh, K.
    Niho, S.
    Goto, K.
    Ohmatsu, H.
    Nishiwaki, Y.
    Saijo, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 392S - 392S
  • [7] Prognostic significance of Notch ligands in patients with non-small cell lung cancer
    Pancewicz-Wojtkiewicz, Joanna
    Eljaszewicz, Andrzej
    Kowalczuk, Oksana
    Niklinska, Wieslawa
    Charkiewicz, Radoslaw
    Kozlowski, Miroslaw
    Miasko, Agnieszka
    Moniuszko, Marcin
    [J]. ONCOLOGY LETTERS, 2017, 13 (01) : 506 - 510
  • [8] Prognostic significance of RelB overexpression in non-small cell lung cancer patients
    Qin, Hualong
    Zhou, Jun
    Zhou, Peng
    Xu, Jingjing
    Tang, Zaixiang
    Ma, Haitao
    Guo, Feng
    [J]. THORACIC CANCER, 2016, 7 (04) : 415 - 421
  • [9] Prognostic significance of dysadherin expression in patients with non-small cell lung cancer
    Tamura, M
    Ohta, Y
    Tsunezuka, Y
    Matsumoto, I
    Kawakami, K
    Oda, M
    Watanabe, G
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (03): : 740 - 745
  • [10] TREATMENT OF ELDERLY NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS - A PROGNOSTIC INDEX
    Clement, D.
    Marinca, M.
    Miron, L.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 209 - 209
12345